Abnormalities in expression of growth factors and their signal transduction systems are often correlated with tumorigenesis. Midkine (MK), found as a product of a retinoic acid-responsive gene, is a heparin-binding growth factor (Kadomatsu, 1988; Tomomura et al, 1990; Muramatsu, 1993) . MK is structually unrelated to fibroblast growth factor, and has about 50% sequence identity to pleiotrophin (PTN) (Muramatsu, 1993) . MK and PTN promote neurite outgrowth (Merenmies and Rauvala, 1990; Muramatsu and Muramatsu, 1991) and enhance plasminogen activator activity of endothelial cells (Kojima et al, 1995a; Kojima et al, 1995b) . Recent evidence indicates a close correlation between MK overexpression and tumorigenesis. MK was reported to be strongly expressed in all cases of Wilms' tumour (Tsusui et al, 1993) , and WT 1, the product of the Wilms' tumour-suppressor gene, suppresses human MK promoter activity (Adachi et al, 1996) . MK expression is increased compared with adjacent noncancerous tissue in more than 80% of gastrointestinal carcinomas such as hepatocellular, oesophageal, pancreatic, colon and stomach carcinomas (Aridome et al, 1995) . Although the frequency was not high, PTN expression has also been reported to be increased in some tumours (Czubyko et al, 1996; Schulte et al, 1996) . Overexpression of MK has also been seen in breast and lung carcinomas (Garver et al, 1994a,b) . Furthermore, strong MK expression correlated with worse prognosis of patients with neuroblastoma and urinary bladder carcinoma (Nakagawara et al, 1995; O'Brien et al, 1996) . Overexpression of MK and PTN in man appears to contribute to the malignant phenotype of carcinomas. Firstly, transfection and expression of MK cDNA or PTN cDNA transform NIH3T3 cells and these cells can form tumours in nude mice (Chauhan et al, 1993; Kadomatsu et al, 1997) . Secondly, MK and PTN have angiogenic activity Schulte et al, 1996; Choudhuri et al, 1997) , and ribozymetargeting of PTN results in decreased invasion of melanoma and choriocarcinoma .
A truncated form of MK mRNA, which encodes MK devoid of the N-terminally located domain, was found in Wilms' tumour, pancreatic carcinoma, gastric carcinoma, colon carcinoma and breast carcinoma but not in adjacent normal tissue Miyashiro et al, 1996 Miyashiro et al, , 1997 . The truncated MK is essentially composed of functionally important C-terminally located domain (Muramatsu et al, 1994; Kojima et al, 1995c) , and is shortlived because of the lack of N-terminally located domain, which protects the C-terminally located domain from protease attack (Matsuda et al, 1996) . This truncated form of MK mRNA may have diagnostic value. As the number of cases examined to date was small, we examined 47 specimens of gastrointestinal carcinomas and corresponding non-cancerous adjacent tissues for the expression of truncated MK mRNA. Lymph node metastases and hepatic metastases were also examined to determine whether there is any correlation between the expression of the truncated form MK mRNA and metastasis.
MATERIALS AND METHODS Surgically resected specimens
Specimens were obtained from 47 patients who had undergone surgery at Kagoshima University Hospital, Kagoshima University, from July 1992 to December 1994. They were immediately frozen and kept at -80°C. The samples were identical to those described previously (Aridome et al, 1995) . The mean age of the patients was 61.5 years and the male/female ratio was 1.9. (Chomczynski et al, 1987) . Total RNA (20 .tg) was denatured, electrophoresed through 1% agarose gels and transferred onto Hybond nylon membranes (Amersham UK). The MK probe was a 487-bp human cDNA fragment (nucleotides 76-562), and 2-kb-pair human P-actin cDNA (Clontech) was also used as a reference probe. The membranes were prehybridized, and then hybridized with radiolabelled probes. Hybridized membranes were washed twice with 2 x SSC, 0.1% sodium dodecylsulphate (SDS) at 56°C for 10 min, twice with 0.2 x SSC, 0.1I% SDS at 56°C for 30 min and exposed to X-ray film.
cDNA synthesis cDNA from total RNA was synthesized with the Superscript II preamplification system (Gibco-BRL, MD, USA). Briefly, 3 gg of total RNA was digested with RNAase-free DNAase, incubated at 70°C to inactivate the enzyme and denatured and hybridized with random hexamer primers. Then first-strand cDNA was synthesized by reverse transcriptase and RNA was digested by RNAase H. The first-strand cDNA was used as the template for polymerase chain reaction (PCR). 
MK expression in metastatic sites
It is noteworthy that truncated MK was expressed in all of 14 metastatic lymph nodes from ten patients but not in one para-aortic lymph node obtained from a non-tumour-bearing patient with abdominal aortic aneurysm (Figure 3 ). In all of ten patients with nodal involvement, both primary tumour and metastatic lymph node expressed truncated MK. On the other hand, in three samples from hepatic metastatic sites (cases 2, 40 and 47), full-size MK was expressed but the truncated type was not (Figure 4) Miyashiro et al, 1996 Miyashiro et al, , 1997 . These results are British Joumal of Cancer (1998) 78(4), 472-477
inconclusive, except in colon and breast carcinoma. Furthermore, the present study also revealed the existence of truncated MK in hepatocarcinoma and oesophageal carcinoma.
Two cases of familial polyposis with colon carcinoma (cases 18 and 21, Table 1 ) were of special interest from the view point of tumour-specific expression of truncated MK: in both cases, truncated MK was detected in the cancerous region, but not in the polypoid region. Truncated MK was also expressed in low-grade malignant cancer of the pancreas (case 43, Table 1 ). Thus, cancer status of the tumour region appears to determine whether truncated MK is expressed.
The full-size MK was detected by RT-PCR in most cancerous and non-cancerous regions. This conclusion is consistent with data reported in previous publications (Aridome et al, 1995) , although quantitative Northern blotting analysis revealed stronger MK expression in more of the cancerous tissues than corresponding non-cancerous tissue (Aridome et al, 1995) . Because of the higher sensitivity of RT-PCR, the number of MK-positive cases in the present study was slightly increased in both cancerous and noncancerous specimens compared with the previous report (Aridome et al, 1995) in which Northern blotting analysis was employed. However, it should be noted that MK was not detected in normal liver even using RT-PCR.
The most interesting finding of the present study was that all of 14 lymph node metastases from ten cancer patients expressed the truncated MK mRNA. The finding suggests the possible importance of the truncated MK in lymph node metastasis. In addition, truncated MK may have diagnostic value. Further studies in this subject are urgently required.
All of three cases of metastatic tumours in the liver did not express truncated MK. Furthermore, the expression of full-size MK mRNA was decreased in the hepatic metastatic lesions as determined by quantitative Northern blotting analysis (data are not shown). Therefore, it is possible that both truncated and full-size MK are correlated with nodal metastasis rather than hepatic metastasis.
There have been reports that molecular biological examination is useful for detecting micrometastasis in cancer patients (Hayashi et al, 1994; Hayashi et al, 1995; Inoue et al, 1995; Mori et al, 1995) . Inoue et al ( 1995) found hepatic micrometastasis in pancreatic adenocarcinoma patients using a two-stage PCR reaction/restriction fragment length polymorphism analysis, which detected the K-ras mutation. Concerning lymph node metastases of gastrointestinal carcinomas, a mutant-allele-specific amplification method was used to detect tumour cells with K-ras or p53 mutation (Hayashi et al, 1994 (Hayashi et al, , 1995 . Cancer cells in lymph nodes were also detected by carcinoembryonic antigen-specific nested reverse transcriptase polymerase chain reaction (Mori et al 1995) . Because of the cancer-specific expression of truncated MK, MKspecific RT-PCR should be useful for the detection of metastatic cancer cells in lymph nodes. MK-specific RT-PCR would be especially helpful in accurate diagnosis of borderline lesions between malignant tumours and benign diseases.
A remaining question is that of the relevance of the truncated transcript to cancer biology. Staining of cancer specimens with anti-MK antibody, which will recognize both the intact and the truncated MK protein, revealed that the cancer cells and not the infiltrating inflammatory cells produce the MK antigen (Aridome et al, 1995) . The truncated MK retains the C-terminally located domain, which is responsible for at least two MK activities, neurite outgrowth (Muramatsu et al, 1994 ) and enhancement of plasminogen activator activity (Kojima et al., l995c) . Thus, it is not likely that the truncated MK exerts some unusual activity. However, the truncated MK is more susceptible to protease (Matsuda et al., 1996) , and a proteolytically produced fragment may either interfere with normal MK function or may have new function relevant to tumour invasion. Several experiments are possible to test the hypotheses.
